Literature DB >> 30732528

CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.

Marco Castro1, Bàrbara Laviña1, Koji Ando1, Alberto Álvarez-Aznar1, Abdallah Abu Taha1, Cord Brakebusch2,3, Elisabetta Dejana1,4, Christer Betsholtz1, Konstantin Gaengel1.   

Abstract

RATIONALE: Aberrant formation of blood vessels precedes a broad spectrum of vascular complications; however, the cellular and molecular events governing vascular malformations are not yet fully understood.
OBJECTIVE: Here, we investigated the role of CDC42 (cell division cycle 42) during vascular morphogenesis and its relative importance for the development of cerebrovascular malformations. METHODS AND
RESULTS: To avoid secondary systemic effects often associated with embryonic gene deletion, we generated an endothelial-specific and inducible knockout approach to study postnatal vascularization of the mouse brain. Postnatal endothelial-specific deletion of Cdc42 elicits cerebrovascular malformations reminiscent of cerebral cavernous malformations (CCMs). At the cellular level, loss of CDC42 function in brain endothelial cells (ECs) impairs their sprouting, branching morphogenesis, axial polarity, and normal dispersion within the brain tissue. Disruption of CDC42 does not alter EC proliferation, but malformations occur where EC proliferation is the most pronounced during brain development-the postnatal cerebellum-indicating that a high, naturally occurring EC proliferation provides a permissive state for the appearance of these malformations. Mechanistically, CDC42 depletion in ECs elicited increased MEKK3 (mitogen-activated protein kinase kinase kinase 3)-MEK5 (mitogen-activated protein kinase kinase 5)-ERK5 (extracellular signal-regulated kinase 5) signaling and consequent detrimental overexpression of KLF (Kruppel-like factor) 2 and KLF4, recapitulating the hallmark mechanism for CCM pathogenesis. Through genetic approaches, we demonstrate that the coinactivation of Klf4 reduces the severity of vascular malformations in Cdc42 mutant mice. Moreover, we show that CDC42 interacts with CCMs and that CCM3 promotes CDC42 activity in ECs.
CONCLUSIONS: We show that endothelial-specific deletion of Cdc42 elicits CCM-like cerebrovascular malformations and that CDC42 is engaged in the CCM signaling network to restrain the MEKK3-MEK5-ERK5-KLF2/4 pathway.

Entities:  

Keywords:  CCM; CDC42; cerebrovascular disorders; endothelial cells; vascular malformations

Mesh:

Substances:

Year:  2019        PMID: 30732528     DOI: 10.1161/CIRCRESAHA.118.314300

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier.

Authors:  Nicolas Santander; Carlos O Lizama; Eman Meky; Gabriel L McKinsey; Bongnam Jung; Dean Sheppard; Christer Betsholtz; Thomas D Arnold
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Editome landscape of CCM-derived endothelial cells.

Authors:  Concetta Scimone; Simona Alibrandi; Luigi Donato; Concetta Alafaci; Antonino Germanò; Sergio L Vinci; Rosalia D'Angelo; Antonina Sidoti
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

3.  Fibroblast growth factors: the keepers of endothelial normalcy.

Authors:  Michael Simons
Journal:  J Clin Invest       Date:  2021-09-01       Impact factor: 19.456

4.  PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.

Authors:  Aileen A Ren; Daniel A Snellings; Yourong S Su; Courtney C Hong; Marco Castro; Alan T Tang; Matthew R Detter; Nicholas Hobson; Romuald Girard; Sharbel Romanos; Rhonda Lightle; Thomas Moore; Robert Shenkar; Christian Benavides; M Makenzie Beaman; Helge Müller-Fielitz; Mei Chen; Patricia Mericko; Jisheng Yang; Derek C Sung; Michael T Lawton; J Michael Ruppert; Markus Schwaninger; Jakob Körbelin; Michael Potente; Issam A Awad; Douglas A Marchuk; Mark L Kahn
Journal:  Nature       Date:  2021-04-28       Impact factor: 49.962

Review 5.  Mouse models of vascular development and disease.

Authors:  Ondine Cleaver
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.218

6.  Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution.

Authors:  Fabrizio Orsenigo; Lei Liu Conze; Suvi Jauhiainen; Monica Corada; Francesca Lazzaroni; Matteo Malinverno; Veronica Sundell; Sara Isabel Cunha; Johan Brännström; Maria Ascención Globisch; Claudio Maderna; Maria Grazia Lampugnani; Peetra Ulrica Magnusson; Elisabetta Dejana
Journal:  Elife       Date:  2020-11-03       Impact factor: 8.140

7.  Chemokine mediated signalling within arteries promotes vascular smooth muscle cell recruitment.

Authors:  Amber N Stratman; Margaret C Burns; Olivia M Farrelly; Andrew E Davis; Wenling Li; Van N Pham; Daniel Castranova; Joseph J Yano; Lauren M Goddard; Oliver Nguyen; Marina Venero Galanternik; Timothy J Bolan; Mark L Kahn; Yoh-Suke Mukouyama; Brant M Weinstein
Journal:  Commun Biol       Date:  2020-12-04

Review 8.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

Review 9.  Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation.

Authors:  Shu Wei; Ye Li; Sean P Polster; Christopher R Weber; Issam A Awad; Le Shen
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

Review 10.  Endothelial cells on the move: dynamics in vascular morphogenesis and disease.

Authors:  Catarina G Fonseca; Pedro Barbacena; Claudio A Franco
Journal:  Vasc Biol       Date:  2020-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.